More OncoSil Medical Ltd news
OncoSil Medical LtdASX: OSL

Additional Binding Commitment Received for Entitlement Offer

Apr 21, 2023 at 12:23 AM EDT · Issued by OncoSil Medical Ltd

Filed with ASX · Apr 21, 2023 at 12:23 AM EDT

On 6ix: 6ix.com/news/additional-binding-commitment-received-for-entitlement-offer

Oncosil Medical Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

OncoSil Medical Ltd on 6ix

Story so far

  • Entitlement Offer PresentationMar 17, 2023
  • Entitlement Offer to raise up to $9.9 millionMar 17, 2023
  • Entitlement Offer Results and Shortfall NotificationJun 9, 2022

Earlier from OncoSil Medical

  • Non-renounceable Rights Issue Offer ProspectusMar 19, 2023
  • Commitment received for Offer and updated TimetableMar 17, 2023
  • Entitlement Offer PresentationMar 16, 2023
  • Entitlement Offer to raise up to $9.9 millionMar 16, 2023
  • Half-Yearly Report ResultsFeb 28, 2023

Later from OncoSil Medical

  • Further commercial milestones achieved in SpainApr 23, 2023
  • Oral presentation at The Mayo Clinic IMPACT CourseApr 23, 2023
  • First year anniversary of the OSPREY post-marketing registryApr 30, 2023
  • OncoSil to streamline operating structureMay 1, 2023
  • First patient enrolled in the TRIPP-FFX Clinical StudyMay 2, 2023
All OncoSil Medical news releases↗

Follow OncoSil Medical into a list and get an email when it puts out news.

Follow OncoSil Medical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer